Global Report - Pharmaceutical Executive

ADVERTISEMENT

Click Here to take survey

Is FDA warranted in delaying approval of Lillys Prasugrel?
Yes
No
Yes
65%
No
35%
Global Report
News, markets, and regulation in Europe, Asia, and South America.
  • Doing More With Less


    In order to take a big step forward, GSK looks to employ smaller licensing deals and business units

    Jumping the Gun


    Britain's new approach to drug pricing isn't as bad as the industry feared.

    Tightening the Chain


    EU makes plans to police its supply chain

    British Biotech Blues


    Can ceasing trade sales and finding funding help UK biotechs became an industry in their own right?

    Fire and NICE



    UK agency takes the heat for slow evaluations and failing to consider societal benefits of new drugs

    Wholesale Change: UK Responds to the Single-Supplier Practice



    Will the sole-wholesaler approach mean higher costs for NHS?

    Oxfam Points Finger



    Pharma defends itself against claims made in charity's report on drug access for the world's poor

    Inviting Innovation



    One of industry's main complaints is that delaying the introduction of new medicines is a particularly simple way of saving money

    India vs. China



    Will CROs continue to operate in India, or will Novartis' pullout send them farther East?

ADVERTISEMENT

ADVERTISEMENT

 
PharmExec Country Reports
Comprehensive reports of the pharmaceutical market in emerging countries across the globe.
Click to View
 
Events and Special Offers Gallery
Click here